Abstract
Extrapleural pneumonectomy (EPP) is a formidable surgical procedure performed on patients with limited life expectancy. Anesthetic management may contribute to containment of perioperative morbidity and mortality through the control of intraoperative physiologic disruptions and postoperative pain and an appreciation of the associated postoperative complications to affect early intervention. “EPP-specific” anesthetic concerns (above those for standard pneumonectomy) are discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wolf AS, Flores RM. Extrapleural pneumonectomy for pleural malignancies. Thorac Surg Clin. 2014;24:471–5.
Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31(1):15–24.
Cao CQ, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol. 2010;5:1692–703.
Burt BM, Cameron RB, Mollberg NM, Kosinski AS, Schipper PH, Shrager JB, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148:30–5.
Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128(1):138–46.
Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117(1):54–63. discussion 63-5.
Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009;138(2):405–11.
Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the international mesothelioma interest group congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013;145(4):909–10.
Cao C, Tian D, Manganas C, Matthews P, Yan TD. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg. 2012;1(4):428–37.
Hartigan PM, Ng JM. Anesthetic strategies for patients undergoing extrapleural pneumonectomy. Thorac Surg Clin. 2004;14(4):575–83, xi.
Ng JM, Hartigan PM. Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol. 2008;21(1):21–7.
Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin. 2004;14(4):469–77, viii.
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29(1):2–17.
Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17(6):525–34.
Carroll N, Mohamed F, Sugarbaker P. Hyperthermic chemoperfusion, and postoperative chemotherapy: The National Cancer Institute and Washington hospital center experience. In: Pass H, Vogelzang N, Carbone M, editors. Malignant mesothelioma: advances in pathogenesis, diagnosis and translational therapies. New York: Springer; 2005. p. 732–54.
Lee JM, Sugarbaker DJ. Extrapleural pneumonectomy for pleural malignancies. In: Sugarbaker DJ, Bueno R, Colson YL, Jaktlisch MT, Krasna MJ, Mentzer SJ, editors. Adult chest surgery. 2nd ed. New York: McGraw-Hill Professional; 2015. p. 998–1009.
Reilly JJ Jr. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999;116(6 Suppl):S474–6.
Amar D, Burt ME, Roistacher N, Reinsel RA, Ginsberg RJ, Wilson RS. Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg. 1996;61(2):516–20.
Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21(2):111–20.
Slinger P. Update on anesthetic management for pneumonectomy. Curr Opin Anaesthesiol. 2009;22(1):31–7.
Wittnich C, Trudel J, Zidulka A, Chiu RC. Misleading “pulmonary wedge pressure” after pneumonectomy: its importance in postoperative fluid therapy. Ann Thorac Surg. 1986;42(2):192–6.
Brister NW, Barnette RE, Kim V, Keresztury M. Anesthetic considerations in candidates for lung volume reduction surgery. Proc Am Thorac Soc. 2008;5(4):432–7.
Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86(3):598–612.
Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93(4):853–8.
Oka T, Ozawa Y, Ohkubo Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth Analg. 2001;93(2):253–9. 1st contents page.
Nino M, Body SC, Hartigan PM. The use of a bronchial blocker to rescue an ill-fitting double-lumen endotracheal tube. Anesth Analg. 2000;91(6):1370–1, TOC.
Senturk M, Slinger P, Cohen E. Intraoperative mechanical ventilation strategies for one-lung ventilation. Best Prac Res Clin Anaesthesiol. 2015;29(3):357–69.
Hurford WE, Kolker AC, Strauss HW. The use of ventilation/perfusion lung scans to predict oxygenation during one-lung anesthesia. Anesthesiology. 1987;67(5):841–4.
Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, et al. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg. 2007;84(3):982–6.
Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 1995;9(4):442–51.
Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg. 2008;85(1):257–64.
Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27(3):373–8.
de Perrot M, McRae K, Anraku M, Karkouti K, Waddell TK, Pierre AF, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85(4):1206–10.
Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79(5):1698–703.
Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130(2):438–44.
Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary. J Thorac Cardiovasc Surg. 2014;148(3):772–91.
Brown MJ, Brown DR. Thoracic cavity irrigation: an unusual cause of acute ST segment increase. Anesth Analg. 2002;95(3):552–4, table of contents.
Obata H, Saito S, Fujita N, Fuse Y, Ishizaki K, Goto F. Epidural block with mepivacaine before surgery reduces long-term post-thoracotomy pain. Can J Anaesth. 1999;46(12):1127–32.
Senturk M, Ozcan PE, Talu GK, Kiyan E, Camci E, Ozyalcin S, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94(1):11–5, table of contents.
Suzuki M, Haraguti S, Sugimoto K, Kikutani T, Shimada Y. Sakamoto A. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology. 2006;105(1):111–9.
Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009;21(2):132–48.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Clinical Case Discussion
Clinical Case Discussion
Case
A 50 year-old male is scheduled for right extrapleural pneumonectomy. The diagnosis of mesothelioma was made on pleural biopsy, and he has completed six cycles of chemotherapy. He is a nonsmoker, and apart from well-controlled hypertension, he has no other significant comorbidities.
Questions
-
1.
Apart from routine preoperative assessment for pulmonary resection:
-
(a)
Are any specialized cardiac and pulmonary function tests indicated?
-
Echocardiography commonly used to assess cardiac function.
-
Stress test only when history, examination, and echocardiography suggest significant cardiac disease.
-
FEV1, DLCO, and exercise capacity routinely assessed.
-
Ventilation/perfusion scans recommended if FEV1 < 2 L.
-
Predicted postoperative FEV1 < 1 L may preclude EPP.
-
-
(b)
What is the importance of radiologic investigations?
-
Surgical staging and tumor resectability.
-
Anesthetic implications include safe placement of epidural catheters at the thoracic region, level of intravenous access, quantity of blood and blood products available, and the potential necessity for cardiopulmonary bypass during resection.
-
-
(a)
-
2.
How is an extrapleural pneumonectomy different from pneumonectomy?
-
See Table 36.3.
-
-
3.
What are the common causes of hypotension and the management strategies? (Table 36.5)
-
4.
How would the application of intraoperative intracavitary heated chemotherapy affect the anesthetic management?
-
Renal protective strategies should be employed (Table 36.1).
-
Restrictive physiology exhibited by EPP patients during one-lung ventilation is exacerbated by the weight of the perfusate, and positive end-expiratory pressure is especially important to prevent atelectasis.
-
Fluid management is delicate balance between renal protection and the potential for exacerbation of acute lung injury in fluid overload.
-
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ng, JM. (2019). Extrapleural Pneumonectomy. In: Slinger, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-00859-8_36
Download citation
DOI: https://doi.org/10.1007/978-3-030-00859-8_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00858-1
Online ISBN: 978-3-030-00859-8
eBook Packages: MedicineMedicine (R0)